ArticleCureus2026
Phase-Dependent Changes in Heart Rate Variability During the Menstrual Cycle in Healthy Young Women at a Tertiary Care Center.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The menstrual cycle is characterized by cyclical hormonal fluctuations of estrogen and progesterone that influence multiple physiological systems, including the cardiovascular and autonomic nervous systems. Heart rate variability (HRV) is a widely accepted, non-invasive method for assessing autonomic nervous system activity. This study aimed to evaluate HRV across different phases of the menstrual cycle in young, healthy female students. Methodology This observational study was conducted in the Department of Physiology at Maharishi Markandeshwar Institute of Medical Sciences and Research (MMIMSR), Mullana, Ambala, over 18 months. Fifty healthy female students aged 18-30 years with regular menstrual cycles were included. HRV was recorded using electrocardiography during the menstrual, proliferative, ovulatory, and secretory phases. Frequency-domain parameters were analyzed using SPSS software (IBM SPSS Statistics for Windows, IBM Corp., Version 23.0, Armonk, NY). Results Fifty healthy women (mean age: 20.3 ± 2.6 years) were included. High-frequency (HF) power varied significantly across menstrual phases (F = 15.28, p < 0.001), increasing from 807 ± 949 ms² during the menstrual phase to 2118 ± 2013 ms² in the proliferative phase and 1753 ± 1498 ms² during ovulation before decreasing to 912 ± 1194 ms² in the secretory phase. Low-frequency (LF) power also showed significant phase-dependent variation (F = 8.48, p < 0.001), whereas the LF/HF ratio did not differ significantly between phases (F = 0.74, p = 0.529). Post hoc analysis demonstrated significantly higher HF power during the proliferative and ovulatory phases compared with the menstrual and secretory phases (all p ≤ 0.002), indicating greater parasympathetic activity during estrogen-dominant phases. Conclusion HRV demonstrates phase-dependent variation across the menstrual cycle, with increased parasympathetic activity during the proliferative and ovulatory phases. Consideration of the menstrual phase is important when interpreting HRV findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.